coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Chester Central PCN, Cheshire West and Chester (LAD) · Health Inequalities Profile

    PCN U42807 · NHS Cheshire and Merseyside Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    39,176

    Registered population

    66.5% aged 18–64

    19.6%

    Aged 65+

    ICB 19.0% · England 17.9%

    7.6%

    Ethnic minority (non-White)

    3.5% Asian · England 9.6%

    20.4%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~5,175

    Core20 residents (est.)

    Resident basis; registered basis ~8,648 · see page 3

    5,898

    Hypertension register

    +3.50% in 3 yrs · England +5.60%

    611

    SMI register

    16.2% of Cheshire West and Chester (LAD)'s

    827

    COPD register

    Reviews -8.34% in 3 yrs

    Forecast to 2030

    6,543

    Hypertension patients, 2030

    +645 on today

    65.2%

    QRISK ≥20% on statins, 2030

    +0.66pp over 3 yrs

    5.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -8.3%
    Respiratory reviews and smoking offers declined.

    COPD annual reviews fell 8.3% over three years (England +2.8%), asthma reviews reached 64.1% (about 900 unreviewed), and smoking support offers fell 8.2 pp.

    85.1%
    Age-five boosters and cervical screening trail.

    Age-5 MMR dose 2 is 85.1% (below the 95.0% target by 9.9 pp), 4-in-1 is 83.6%, and younger cervical screening is 61.2% (LAD 72.1%).

    72.4%
    Cardiovascular and diabetes control exceed England.

    Hypertension treatment to target is 72.4% (England 70.3%), non-frail diabetes HbA1c control is 59.4% (England 57.4%), and 12-month 6-in-1 coverage reaches 98.4%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults represent 19.6% of patients alongside 26 care homes in the catchment

    Across 39,176 registered patients in six practices, 19.6% are aged 65+ (7,685 patients; England 17.9%; LAD 20.3%; ICB 19.0%), 66.5% are aged 18-64 (England 62.7%), and 13.9% are aged 0-17 (England 19.6%). Learning disability prevalence is 0.6% (220 patients; England 0.6%). Census resident figures show 7.6% ethnic minority population (Asian 3.5%, Mixed 2.0%, Black 1.1%, Other 1.0%; White 92.4%), exceeding LAD (2.0% Asian) and ICB (2.8%) but below England (9.6%). Census data reflects resident areas rather than practice-registered lists.

    Age profile

    0–1713.9%
    18–6466.5%
    65+19.6%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White92.4%
    Asian3.5%
    Mixed2.0%
    Black1.1%
    Other1.0%

    Older people · falls rows are Cheshire West and Chester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire West and Chester LA)2,1092,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire West and Chester LA)8931,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire West and Chester LA)14.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 20.4%, exceeding the local authority average of 15.7%

    Core20 cohort (IMD quintile 1) is 20.4% at PCN level, above Cheshire West and Chester (LAD) (15.7%), below NHS Cheshire and Merseyside Integrated Care Board (31.9%) and below England (21.0%). This is above the comparator, which may reflect need or recording; check which before changing capacity.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Northgate27.0% · 2,254 patients
    Elms26.6% · 2,607 patients
    Northgate Village26.3% · 1,764 patients
    Garden Lane16.3% · 1,520 patients
    Fountains Medical10.9% · 503 patients
    St Werburgh's0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    611

    SMI register

    1.52% recorded prevalence

    220

    Learning disability register

    0.55% recorded prevalence

    26

    Care homes, 1,068 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Cheshire West and Chester (LAD), Census 2021

    Recorded severe mental illness prevalence is 1.5% (611 patients), above Cheshire West and Chester LAD (1.0%), ICB (1.1%), and England (1.0%). The PCN catchment includes 26 care homes with 1,068 beds, though resident registrations are unconfirmed. Cheshire West and Chester local authority rough sleeping snapshot was 29 in 2025. Recorded SMI prevalence of 1.5% exceeds the England average of 1.0% across the registered population.

    Severe mental illness: physical health checks

    SMI prevalence is 1.5% (England 1.0%). Recorded blood pressure is 84.7% (England 83.4%) and BMI is 84.5% (England 82.1%), but smoking cessation offers fell 8.2 pp over three years to 88.0% (England 94.2%, +0.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,898

    Hypertension register

    +3.50%

    Register growth, 3 yrs

    Cheshire West and Chester (LAD) +6.60% · England +5.60%

    +0.08pp

    BP control, under 80

    ≤140/90 · −1.68pp aged 80+

    +645

    More patients by 2030

    Forecast 6,543 (15.68%)

    Hypertension case-finding and control

    Hypertension: QOF prevalence is 14.6% at PCN level, below Cheshire West and Chester (LAD) (17.0%), below NHS Cheshire and Merseyside Integrated Care Board (16.8%) and below England (15.2%). Recorded hypertension is lower than comparators, which may reflect population age structure; case-finding review would test whether under-detection contributes.

    Lipids and statins

    Patients with QRISK ≥ 20% treated with lipid lowering therapy is 63.9% at PCN level, above Cheshire West and Chester (LAD) (63.8%), above NHS Cheshire and Merseyside Integrated Care Board (63.2%) and above England (63.6%). Lipid-lowering coverage is above the comparator, so the priority is keeping reach and reviewing who remains untreated.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202659,529£1.70£1.71£1.86£101,199
    Cardiovascular (all), 202583,506£6.09£4.37£3.33£508,552

    Cost per item for Lipid-regulating drugs 2026 is £1.70 at PCN level, above Cheshire West and Chester (LAD) (£1.44), below NHS Cheshire and Merseyside Integrated Care Board (£1.71) and below England (£1.86). Unit cost is above the local authority comparator but below England and the ICB; formulary review would clarify cost drivers.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.02%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.35%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.0% (827 patients); reviews reached 73.3% (LAD 71.0%; ICB 74.6%; England 76.4%), falling 8.3% over three years (England +2.8%). Asthma prevalence is 6.5% (2,518 patients); reviews fell 2.0% over three years to 64.1% (England 65.7%, +4.4%), leaving about 900 unreviewed patients. Asthma prescribing for ages 5-19 is 2,033 items per 1,000 (England 1,488). Practice recall audits would test whether this reflects administrative gaps.

    Cancer register and children's immunisation

    Cancer register prevalence is 4.3% (1,746 patients), above England (3.8%). Childhood immunisation meets the 95.0% target at 12 months for 6-in-1 at 98.4% (England 91.0%), but age-5 boosters fall short: 4-in-1 is 83.6% (11.4 pp below target) and MMR dose 2 is 85.1% (9.9 pp below target, and 4.5 pp below dose 1 in the same cohort). Cohort audit would test if this reflects recall attrition.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.4%

    England 91.0%

    6-in-1 complete primary course at 24 months96.9%

    England 92.2%

    MMR dose 1 at 24 months90.6%

    England 88.3%

    MMR dose 2 at age 585.1%

    England 82.8%

    4-in-1 pre-school booster at age 583.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    At PCN level, cervical screening coverage for women aged 25-49 is 61.2%, trailing Cheshire West and Chester LAD (72.1%) and England (66.8%), after a 3-year change of -3.2% (England -1.0%). In contrast, breast screening rose +14.4% to 73.5% (England 69.9%). Across the wider system, 55.5% of cancers with a known stage in NHS Cheshire and Merseyside ICB were diagnosed at stage 1 or 2 in 2022 (7,482 of 13,490; England 55.3%), with 72.8% staged overall (13,490 of 18,522), trailing the 75.0% national ambition by 2028 (about 2,640 extra early cases needed; ICB data, not PCN performance). Persistent cervical screening gaps may delay detection unless primary care recall is expanded.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Countess of Chester Hospital NHS Foundation Trust achieved 87.4% on the 28-day faster diagnosis standard (standard 75.0%), ahead of North Cheshire and Mersey NHS Foundation Trust (80.2%), Wirral University Teaching Hospital NHS Foundation Trust (74.7%), the ICB (77.2%), and England (79.3%). On 62-day treatment, Countess reached 83.3% (standard 85.0%), below North Cheshire and Mersey (83.7%) but above Wirral (77.6%), the ICB (76.2%), and England (71.2%). In diagnostics, 11.3% of MRI and 19.1% of ultrasound patients waited 6+ weeks (England 21.4% and 19.6%). Acute diagnostic turnaround remains comparatively strong despite specific modality backlogs.

    Pathways within standard (%)Countess of ChesterNorth Cheshire and MerseyWirralCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)87.3780.2174.7177.2579.32
    31-day treatment (96%)93.4898.1792.5395.7192.50
    62-day referral to treatment (85%)83.2883.6777.6576.2371.16
    Diagnostic waits over 6 weeks (%)Countess of ChesterNorth Cheshire and MerseyWirralEngland
    MRI11.260.531.5421.40
    CT4.182.321.559.92
    Echocardiography31.4428.045.0728.48
    Colonoscopy26.4415.9832.8130.83
    Gastroscopy27.5220.2417.7329.02
    All 15 DM01 tests20.166.345.0223.14
    Community services activityCheshire West and Chester residentsCheshire and Merseyside ICB
    Care contacts47,655541,280
    Referrals10,32597,150
    Patients with a contact18,585146,240

    Community services (residents of Cheshire West and Chester), Jun 2026 (provisional). In the provisional June 2026 community services dataset for Cheshire West and Chester LAD residents, adults aged 65+ accounted for 52.7% of all recorded contacts (25,095 of 47,655). With 52.7% of community contacts involving older adults, integrated primary care coordination remains critical.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 43.5 pp and overall satisfaction varies by 28.4 pp

    In 2025/26, QOF overall achievement ranged from 62.0% at St Werburgh's Medical Practice Homeless to 98.2% at Fountains Medical Practice (England 92.5%). Vaccination achievement spanned 84.1 pp, from 0.0% at St Werburgh's to 84.1% at Fountains, with The Elms Medical Centre reaching 18.4% (England 55.2%). High clinical scores elsewhere may mask local immunisation gaps.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    St Werburgh's190.0100.0%69.8%100.0%
    Fountains Medical10310.956.5%75.8%84.7%
    Elms10626.666.8%65.0%83.7%
    Northgate Village10226.379.1%75.4%81.5%
    Northgate9927.066.2%84.3%79.7%
    Garden Lane11316.368.6%73.3%71.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire West and Chester (LAD)AssetPCNCheshire West and Chester (LAD)
    Care homes (catchment)26 (1,068 beds)n/aSchools (catchment)73n/a
    Children's centres315Places of worship61231
    Librariesn/a16Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)1270
    Primary academies746Special schoolsn/a5

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school booster recall and catch-up

    At age 5, MMR dose 2 is 85.1% (below the 95.0% target by 9.9 pp, and 4.5 pp below dose 1 at 89.6% across 67 children) and 4-in-1 is 83.6% (below by 11.4 pp). Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Respiratory review and smoking support recall

    Asthma reviews cover 64.1% of 2,518 patients (England 65.7%; about 900 unreviewed after falling 2.0%), COPD reviews fell 8.3% to 73.3%, and smoking cessation offers fell 8.2 pp to 88.0% (England 94.2%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Younger-cohort cervical screening outreach

    Cervical screening coverage in women aged 25-49 is 61.2%, below Cheshire West and Chester LAD (72.1%, by 10.9 pp), the ICB (68.5%, by 7.3 pp) and England (66.8%, by 5.6 pp), falling 3.2% over 3 years. Low cost, quick to run.

    Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.

    Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register audit (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Pre-school booster catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Primary care access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Pre-school booster recall and catch-up (p12)4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 · MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Respiratory review and smoking support recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD patients with a review in the last 12 monthsCore20PLUS5 respiratoryPCN
    Option 3 · Younger-cohort cervical screening outreach (p12)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15